Oversight indicators & benchmarks for your clinical trial
September 28, 2023, 11:00 ET
Unlock the power of data-driven foresight in clinical trials, make better decisions to prevent quality issues, and optimize study performance with Lokavant’s valuable insights and indicators.
Predictive factors of clinical trial participant discontinuation
March 8, 2022, 3:00 ET
Using our proprietary historical trial data, Lokavant conducted an analysis to investigate key predictive factors that increased or decreased risk of participant discontinuation in COVID-19 impacted clinical trials.
New Lokavant advanced analytics improve enrollment projections
Mar 25, 2021, 09:00 ET
Using machine learning models and a combination of historical and within-trial data, Lokavant was able to predict key enrollment outcomes earlier in a study’s trajectory and with 95% accuracy.
Your guide to decentralized trials and their impact on enrollment
Feb 11th, 2020, 10:00 ET
The pandemic has driven rapid adoption of decentralized clinical trials, but measuring the effectiveness and risk of these efforts on enrollment has been difficult to date.
Lokavant partnered with THREAD to conduct the first ever impact analysis of DCTs on key performance indicators during the pandemic. Using proprietary data from over 300 ongoing COVID-impacted trials and data from THREAD, Lokavant’s analytical platform showcased the ability of decentralized approaches to mitigate COVID-related risks.